Method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -10698.04% · OPTIONAL
· Orthopedic, Prosthetic & Surgical Appliances & Supplies
RESEARCH SNAPSHOTEnvoy Medical, Inc.'s latest supported as-filed period reports revenue of $51,000, 34.6% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -10698.04% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value -34.62% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 3096.08% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value -445.10% · CORE
Level · gp.fundamentals.operating_margin
Raw value -10919.61% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 6141.18% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Operating margin changed -441961 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Revenue changed -34.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
COCH · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001213900-26-094447SEC ↗4Aug 26, 2026Period Aug 24, 20260000914190-26-000137SEC ↗8-KAug 10, 2026Period Aug 10, 20260001213900-26-087221SEC ↗10-QAug 10, 2026Period Jun 30, 20260001213900-26-086974SEC ↗8-KJun 30, 2026Period Jun 24, 20260001213900-26-073659SEC ↗8-KJun 25, 2026Period Jun 19, 20260001213900-26-072033SEC ↗4Jun 23, 2026Period Jun 19, 20260000914190-26-000100SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 24, 2026Filed Aug 26, 2026 | Potashnick RobertCAO & VP of Finance | Grant Or AwardDirect | 250,000 | $0 | $0 | Form 4 ↗ |
| Jun 19, 2026Filed Jun 23, 2026 | Lucas Brent T.Chief Executive Officer | Grant Or AwardDirect | 1,000,000 | $0 | $0 | Form 4 ↗ |
| Jun 19, 2026Filed Jun 23, 2026 | Lucas Brent T.Chief Executive Officer | Grant Or AwardDirect | 1,000,000 | $0 | $0 | Form 4 ↗ |
| May 29, 2026Filed Jun 4, 2026 | Lucas Brent T.Chief Executive Officer | Grant Or AwardDirect | 32,856 | $1 | $19,681 | Form 4 ↗ |
| Apr 15, 2026Filed Apr 17, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 419.61% · OPTIONAL
Inventory / revenue changed +106146 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Research & development changed +26.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Cash & equivalents changed +272.2% from the comparable as-filed period.
Operating income changed -9.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed -5.1% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0000914190-26-000095| McKhann ChasDirector |
| Grant Or AwardDirect |
| 100,000 |
| $0 |
| $0 |
| Form 4 ↗ |
| Feb 12, 2026Filed Feb 17, 2026 | Patel Mona ChetanDirector | Open Market PurchaseDirect | 312,500 | $0 | $125,000 | Form 4 ↗ |
| Feb 12, 2026Filed Feb 17, 2026 | Patel Mona ChetanDirector | Open Market PurchaseDirect | 187,500 | $0 | $0 | Form 4 ↗ |
| Feb 12, 2026Filed Feb 17, 2026 | Patel Mona ChetanDirector | Open Market PurchaseDirect | 312,500 | $0 | $0 | Form 4 ↗ |
| Feb 12, 2026Filed Feb 17, 2026 | Potashnick RobertInterim CFO | Open Market PurchaseDirect | 212,500 | $0 | $85,000 | Form 4 ↗ |
| Feb 12, 2026Filed Feb 17, 2026 | Potashnick RobertInterim CFO | Open Market PurchaseDirect | 127,500 | $0 | $0 | Form 4 ↗ |
| Feb 12, 2026Filed Feb 17, 2026 | Potashnick RobertInterim CFO | Open Market PurchaseDirect | 212,500 | $0 | $0 | Form 4 ↗ |
| Feb 12, 2026Filed Feb 17, 2026 | Kantor SusanDirector | Open Market PurchaseDirect | 96,150 | $0 | $38,460 | Form 4 ↗ |
| Feb 12, 2026Filed Feb 17, 2026 | Kantor SusanDirector | Open Market PurchaseDirect | 57,690 | $0 | $0 | Form 4 ↗ |
| Feb 12, 2026Filed Feb 17, 2026 | Kantor SusanDirector | Open Market PurchaseDirect | 96,150 | $0 | $0 | Form 4 ↗ |
| Feb 12, 2026Filed Feb 17, 2026 | BRYNELSEN CHARLESDirector | Open Market PurchaseDirect | 1,000,000 | $0 | $400,000 | Form 4 ↗ |
| Feb 12, 2026Filed Feb 17, 2026 | BRYNELSEN CHARLESDirector | Open Market PurchaseDirect | 600,000 | $0 | $0 | Form 4 ↗ |
| Feb 12, 2026Filed Feb 17, 2026 | BRYNELSEN CHARLESDirector | Open Market PurchaseDirect | 1,000,000 | $0 | $0 | Form 4 ↗ |
| Feb 12, 2026Filed Feb 17, 2026 | Lucas Brent T.Chief Executive Officer | Open Market PurchaseDirect | 62,500 | $0 | $25,000 | Form 4 ↗ |
| Feb 12, 2026Filed Feb 17, 2026 | Lucas Brent T.Chief Executive Officer | Open Market PurchaseDirect | 37,500 | $0 | $0 | Form 4 ↗ |
| Feb 12, 2026Filed Feb 17, 2026 | Lucas Brent T.Chief Executive Officer | Open Market PurchaseDirect | 62,500 | $0 | $0 | Form 4 ↗ |